Can New Delhi's negotiations with the US for a bilateral trade agreement help India navigate Donald Trump's reciprocal ...
Trump administration's tariffs from April 2 may disrupt India's export economy, risking a $6 billion loss. Strategic concessions and targeted negotiations are crucial.
Eli Lilly's CEO, David Ricks, reveals potential plans to manufacture the weight-loss drug Mounjaro in India as part of their global expansion.
Benchmark indices Sensex and Nifty ended their seven-day winning streak on Wednesday, falling nearly 1% due to profit-booking ...
The import tariff on Harley-Davidson motorcycles was previously brought down from 50% to 40%, while Bourbon whiskey saw a cut ...
India is bracing for the impact of US President Trump's tariffs, particularly on Venezuelan oil imports, which may raise ...
Indian firms sent $36 billion abroad via ODI in FY25, with Singapore, the US, and UK leading; February saw $5.35 billion.
The Hyderabad center is expected to be operational by mid-2025 and will be Lilly’s second capability center in India after ...
The bench said that public good outweighs the company’s profit as the drug is not available at an affordable price in India.
As much as $135 million in value will be unlocked as stock of five companies eligible for trading as their shareholder ...
IST, the barometer index, the S&P BSE Sensex tumbled 328.07 points or 0.43% to 77,689.26. The Nifty 50 index fell 64.30 points or 0.27% to 23,604.35.
The S&P BSE Sensex was down 342.44 points to 77,674.75, while the NSE Nifty50 lost 69.90 points to 23,598.75 as of 12:24 pm. ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results